Technical Assistance Webinars: RFA-NS-24-029: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded

This is a reminder of our upcoming webinars related to RFA-NS-24-029 “Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)”. NIH program and review staff will provide an overview of the RFA, including objectives, application instructions and review criteria and will be available to answer questions. 

Topic: Technical Assistance Webinar: RFA-NS-24-029 – Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) 

Dates: Tuesday, December 12, 2023 and Tuesday, January 9, 2024 

Time: 1pm-2pm Eastern Time (ET) 

Please see the Notice Number NOT-NS-24-036 for additional information, including registration guidance:  https://grants.nih.gov/grants/guide/notice-files/NOT-NS-24-036.html 

NINDS program staff (contact information below) are available to address any questions you may have about RFA-NS-24-029, and to discuss your application should you choose to submit. 

Emily Caporello, Program Director, Division of Translational Research, NINDS, emily.caporello@nih.gov 

Amy Tsou, Program Director, Division of Clinical Research, NINDS, amy.tsou@nih.gov  

Amelie Gubitz, Program Director, Division of Neuroscience, NINDS, gubitza@ninds.nih.gov 

Lumy Sawaki-Adams, Program Director, Division of Clinical Research, NINDS, lumy.sawaki-adams@nih.gov